Vijaya Diagnostic CentreQ1 FY25

Vijaya Diagnostic Centre Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,467.4P/E: 74.2Market Cap: ₹15.1K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Vijaya Diagnostic Centre has seen robust organic growth, with a 20% year-on-year increase excluding PH Pune, driven by volume growth of 20% and footfall growth of 17%.
  • Existing centers (as of FY22) continue growing at double-digit rates (~12-13%) with room for further growth over the next 1-2 years.
  • New centers added in FY23 and FY24 contribute to accelerated growth, with newer hubs delivering higher patient footfall growth (around 17% in the recent quarter).
  • The company expects the double-digit volume and revenue growth to continue, supported by both existing and new centers.
  • Expansion focus remains on hubs, especially in Pune and Kolkata, with plans to add 9 new hubs in 12-18 months to sustain growth.
  • Long-term growth will rely on both organic expansion in existing centers and adding new capacities in newer geographies.
  • EBITDA margins expected to remain stable around 39-40% despite expansion.

See what Vijaya Diagnostic Centre management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • The company has not indicated any current or planned fundraising through debt or equity.
  • Expansion plans for new hub centers in Pune, Kolkata, and adjacent geographies are being funded through internal accruals.
  • The management emphasized strong cash reserves (INR212 crores as of Q1 FY'25) to support growth.
  • There is no mention of external capital raising, implying reliance on internal resources for ongoing and planned expansions.

See what Vijaya Diagnostic Centre management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company has finalized leases for nine new hub locations across home states, Pune, and West Bengal, scheduled to start operations within the next 12 to 18 months.
  • Capex per typical hub ranges from INR 12 to 14 crores; for advanced hubs with 3 Tesla MRI and high-end cardiac CT, capex may be INR 18 to 19 crores.
  • Expansion in new geographies (Pune, Kolkata, adjacent markets) will be funded from internal accruals.
  • The focus is on opening hubs in FY'25, with spokes expected to follow from FY'26 after hubs mature.
  • Equipment additions, including advanced diagnostic devices like 3.0 Tesla MRI and 160-slice cardiac CT, are part of the new hubs.
  • No material drag expected on overall margins from expansion; EBITDA margins around 39%-40% are sustainable despite aggressive growth plans.

Track Vijaya Diagnostic Centre — get its next earnings analysis in your feed

How does Vijaya Diagnostic Centre rank vs peers in Healthcare Services?

Pro feature
ThisVijaya Diagnostic Centre
Rev 3Mar 3

How does Vijaya Diagnostic Centre rank in Healthcare Services?

Compare Vijaya Diagnostic Centre against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →